1.
              Konopleva M, Tabe Y, Zeng Z, Andreeff M (2009) Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches. Drug Resist Updat 12: 103113.
        doi:
        10.1016/j.drup.2009.06.001.
       
                      Find this article online
                    
2.
              Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8: 341352.
        doi:
        10.1038/nrg2101.
       
                      Find this article online
                    
3.
              Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: 17611767.
        doi:
        10.1182/blood-2005-08-3182.
       
                      Find this article online
                    
4.
              Patocs A, Zhang L, Xu Y, Weber F, Caldes T, et al. (2007) Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 357: 25432551. 
                      Find this article online
                    
5.
              Mannello F (2006) Multipotent mesenchymal stromal cell recruitment, migration, and differentiation: what have matrix metalloproteinases got to do with it? Stem Cells 24: 19041907.
        doi:
        10.1634/stemcells.2005-0608.
       
                      Find this article online
                    
6.
              Tilton B, Ho L, Oberlin E, Loetscher P, Baleux F, et al. (2000) Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med 192: 313324.
        doi:
        10.1084/jem.192.3.313.
       
                      Find this article online
                    
7.
              Bachelder RE, Wendt MA, Mercurio AM (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 72037206. 
                      Find this article online
                    
8.
              Muller A, Homey B, Soto H, Ge N, Catron D, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 5056. 
                      Find this article online
                    
9.
              Wiseman BS, Werb Z (2002) Stromal effects on mammary gland development and breast cancer. Science 296: 10461049.
        doi:
        10.1126/science.1067431.
       
                      Find this article online
                    
10.
              Fiegl M, Samudio I, Clise-Dwyer K, Burks JK, Mnjoyan Z, et al. (2009) CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood 113: 15041512.
        doi:
        10.1182/blood-2008-06-161539.
       
                      Find this article online
                    
11.
              Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, et al. (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A 100: 1351313518.
        doi:
        10.1073/pnas.2235846100.
       
                      Find this article online
                    
12.
              Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, et al. (2004) Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6: 409421. 
                      Find this article online
                    
13.
              Rahimi M, George J, Tang C (2010) EGFR variant-mediated invasion by enhanced CXCR4 expression through transcriptional and post-translational mechanisms. Int J Cancer 126: 18501860.
        doi:
        10.1002/ijc.24964.
       
                      Find this article online
                    
14.
              Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, et al. (2004) Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6: 459469.
        doi:
        10.1016/j.ccr.2004.09.027.
       
                      Find this article online
                    
15.
              Kim M, Koh YJ, Kim KE, Koh BI, Nam DH, et al. (2010) CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res 70: 1041110421.
        doi:
        10.1158/0008-5472.CAN-10-2591.
       
                      Find this article online
                    
16.
              Konoplev S, Jorgensen JL, Thomas DA, Lin E, Burger J, et al. (2011) Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia. Cancer 117: 46894695.
        doi:
        10.1002/cncr.26113.
       
                      Find this article online
                    
17.
              Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, et al. (2011) Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res 71: 603613.
        doi:
        10.1158/0008-5472.CAN-10-3185.
       
                      Find this article online
                    
18.
              Jin F, Brockmeier U, Otterbach F, Metzen E (2012) New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation. Mol Cancer Res 10: 10211031.
        doi:
        10.1158/1541-7786.MCR-11-0498.
       
                      Find this article online
                    
19.
              Zhang M, Liu HX, Teng XD, Wang HB, Cui J, et al. (2012) The differences in CXCR4 protein expression are significant for the five molecular subtypes of breast cancer. Ultrastruct Pathol 36: 381386.
        doi:
        10.3109/01913123.2012.728687.
       
                      Find this article online
                    
20.
              Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, et al. (2004) Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. Faseb J 18: 12401242.
        doi:
        10.1096/fj.03-0935fje.
       
                      Find this article online
                    
21.
              Hesselgesser J, Ng HP, Liang M, Zheng W, May K, et al. (1998) Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J Biol Chem 273: 1568715692.
        doi:
        10.1074/jbc.273.25.15687.
       
                      Find this article online
                    
22.
              Kaplan RN, Rafii S, Lyden D (2006) Preparing the soil: the premetastatic niche. Cancer Res 66: 1108911093.
        doi:
        10.1158/0008-5472.CAN-06-2407.
       
                      Find this article online
                    
23.
              Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, et al. (2002) CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 100: 25972606.
        doi:
        10.1182/blood-2002-01-0031.
       
                      Find this article online
                    
24.
              Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, et al. (2007) CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Res 67: 75187524.
        doi:
        10.1158/0008-5472.CAN-06-2263.
       
                      Find this article online
                    
25.
              Zeng Z, Samudio IJ, Munsell M, An J, Huang Z, et al. (2006) Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther 5: 31133121.
        doi:
        10.1158/1535-7163.MCT-06-0228.
       
                      Find this article online
                    
26.
              Liang Z, Wu T, Lou H, Yu X, Taichman RS, et al. (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64: 43024308.
        doi:
        10.1158/0008-5472.CAN-03-3958.
       
                      Find this article online
                    
27.
              Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, et al. (2004) CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 86048612.
        doi:
        10.1158/0008-5472.CAN-04-1844.
       
                      Find this article online
                    
28.
              Ahr B, Denizot M, Robert-Hebmann V, Brelot A, Biard-Piechaczyk M (2005) Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation. J Biol Chem 280: 66926700.
        doi:
        10.1074/jbc.M408481200.
       
                      Find this article online
                    
29.
              Ling X, Konopleva M, Zeng Z, Ruvolo V, Stephens LC, et al. (2007) The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res 67: 42104218.
        doi:
        10.1158/0008-5472.CAN-06-3629.
       
                      Find this article online
                    
30.
              Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 13991405. 
                      Find this article online
                    
31.
              Hail N (2008) Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radic Biol Med 44: 13821393.
        doi:
        10.1016/j.freeradbiomed.2007.12.034.
       
                      Find this article online
                    
32.
              Zeng Z, Shi YX, Samudio IJ, Wang RY, Ling X, et al. (2009) Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood 113: 62156224.
        doi:
        10.1182/blood-2008-05-158311.
       
                      Find this article online
                    
33.
              Hatse S, Princen K, De Clercq E, Rosenkilde MM, Schwartz TW, et al. (2005) AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. Biochem Pharmacol 70: 752761.
        doi:
        10.1016/j.bcp.2005.05.035.
       
                      Find this article online
                    
34.
              Ling X, Arlinghaus RB (2005) Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res 65: 25322536.
        doi:
        10.1158/0008-5472.CAN-04-2425.
       
                      Find this article online
                    
35.
              Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, et al. (2004) MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431: 11121117.
        doi:
        10.1038/nature03043.
       
                      Find this article online
                    
36.
              Azzam HS, Arand G, Lippman ME, Thompson EW (1993) Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85: 17581764.
        doi:
        10.1093/jnci/85.21.1758.
       
                      Find this article online
                    
37.
              Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, et al. (2007) Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res 67: 651658.
        doi:
        10.1158/0008-5472.CAN-06-2762.
       
                      Find this article online
                    
38.
              Hinton CV, Avraham S, Avraham HK (2008) Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis. J Cell Mol Med 12: 15171526.
        doi:
        10.1111/j.1582-4934.2008.00300.x.
       
                      Find this article online
                    
39.
              Harvey JR, Mellor P, Eldaly H, Lennard TW, Kirby JA, et al. (2007) Inhibition of CXCR4-mediated breast cancer metastasis: a potential role for heparinoids? Clin Cancer Res 13: 15621570.
        doi:
        10.1158/1078-0432.CCR-06-1987.
       
                      Find this article online
                    
40.
              Kozin SV, Kamoun WS, Huang Y, Dawson MR, Jain RK, et al. (2010) Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation. Cancer Res 70: 56795685.
        doi:
        10.1158/0008-5472.CAN-09-4446.
       
                      Find this article online
                    
41.
              Fidler IJ, Kim SJ, Langley RR (2007) The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem 101: 927936.
        doi:
        10.1002/jcb.21148.
       
                      Find this article online
                    
42.
              Yang L, Huang J, Ren X, Gorska AE, Chytil A, et al. (2008) Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13: 2335. 
                      Find this article online
                    